Zevra Therapeutics (ZVRA) Enterprise Value (2015 - 2026)
Zevra Therapeutics' Enterprise Value came in at $629.39 million for Q2 2026, up 122.7% from $282.68 million a year earlier and up 79.7% from the prior quarter.
Zevra Therapeutics (ZVRA) Enterprise Value (2015 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Zevra Therapeutics reported Enterprise Value of $38.26 million, down 37.5% year-over-year; for FY2025, it came in at $318.41 million, down 15.8% from FY2024.
- Enterprise Value carries a five-year compound annual growth rate of 26.7% (FY2020 to FY2025).
- Going back by year, Enterprise Value was $378.12 million in FY2024 (+85.1%), $204.32 million in FY2023 (+168.2%), $76.17 million in FY2022 (-84.7%) and $497.45 million in FY2021 (+410.6%).
- The Q2 2026 figure represents the highest quarterly Enterprise Value since Q2 2021.
- Year-over-year, Enterprise Value increased in seven of the last eight quarters, with growth averaging 72.7%.
- The fastest year-over-year change in Enterprise Value over five years came in Q3 2021 (growth of 588.0%), and the weakest in Q4 2022 (a decline of 84.7%).
- Business Quant data shows ZVRA's Enterprise Value at $350.33 million (Q1 2026), $318.41 million (Q4 2025) and $335.12 million (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn |
| 10 | Zevra Therapeutics | 672.94 Mn | -139.77 Mn | 38.18 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 629.39 Mn |
| Mar 31, 2026 | 350.33 Mn |
| Dec 31, 2025 | 318.41 Mn |
| Sep 30, 2025 | 335.12 Mn |
| Jun 30, 2025 | 282.68 Mn |
| Mar 31, 2025 | 346.92 Mn |
| Dec 31, 2024 | 378.12 Mn |
| Sep 30, 2024 | 280.02 Mn |
| Jun 30, 2024 | 156.50 Mn |
| Mar 31, 2024 | 190.02 Mn |
| Dec 31, 2023 | 204.32 Mn |
| Sep 30, 2023 | 91.60 Mn |
| Jun 30, 2023 | 86.14 Mn |
| Mar 31, 2023 | 111.77 Mn |
| Dec 31, 2022 | 76.17 Mn |
| Sep 30, 2022 | 354.68 Mn |
| Jun 30, 2022 | 226.67 Mn |
| Mar 31, 2022 | 244.72 Mn |
| Dec 31, 2021 | 497.45 Mn |
| Sep 30, 2021 | 527.52 Mn |
Zevra Therapeutics Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=ZVRA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "ZVRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=ZVRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();